---
category: news
title: "Lunit AI Analysis Software for Cancer Protein PD-L1 Gets CE-IVD Mark"
excerpt: "South Korea-based Lunit has received a CE-IVD mark for its artificial intelligence (AI) analysis software that focuses on the cancer-associated protein PD-L1. The Scope PD-L1 TPS software, which delivers a tumor proportion score (TPS), was “trained” to ..."
publishedDateTime: 2022-04-29T19:58:00Z
originalUrl: "https://www.fdanews.com/articles/207621-lunit-ai-analysis-software-for-cancer-protein-pd-l1-gets-ce-ivd-mark"
webUrl: "https://www.fdanews.com/articles/207621-lunit-ai-analysis-software-for-cancer-protein-pd-l1-gets-ce-ivd-mark"
type: article

provider:
  name: FDAnews
  domain: fdanews.com

topics:
  - AI

secured: "4pfHIpsLknBPtYZVtyCjWunU5cbx34/Hqfzsx8idYQP9GHkEqNXM4HVj4VVhyeeLWLT2YimWDqWooW7Yobj0AOMo3r27VRDLYKAUaWErKXmv0iWdx913pG7yI2qrExKk9U6cneoyARGi1mRAysppuqK1HFcwJ39AdFL3LYFlQ+qnn3KdTNS//nIyl8o/AU4/powYVWYiCmkLThy7OvTe+6ck9FlmA4O6aj4zG/Bt6QWnFhDm8fmyrU3sGlJzsvDbvCKdKcIlsrER3jP7iH2E+3wQahu6ec4/Sfj63V2R23bkgw/WI0LmhbBEV94qOa/nYSp2Qand/esPE4gXePlZqcoGe11BOVL/QCjWa7xQ5ds=;LVIheBi/PChP138LiPZaog=="
---

